• HOME
    KOREAN
    CHINESS
    SITE MAP
    JOIN
  • Username (Site Login ID)
  • Password
  • Forgot your password?

  • ¼±È£¡¤°áÁ¤ | Cases and Studies of Preference and Decision-Making in Lottery & Gambling | ø¶û¿ & 决ïÒ

    date : 2015-05-20 01:10|hit : 2702
    Article] Association of polymorphisms of dopamine D-2 receptor (DRD2), and dopamine transporter (DAT(1)) genes with schizoid/avoidant behaviors (SAB)
    DocNo of ILP: 7470

    Doc. Type: Article

    Title: Association of polymorphisms of dopamine D-2 receptor (DRD2), and dopamine transporter (DAT(1)) genes with schizoid/avoidant behaviors (SAB)

    Authors: Blum, K; Braverman, ER; Wu, S; Cull, JG; Chen, TJH; Gill, J; Wood, R; Eisenberg, A; Sherman, M; Davis, KR; Matthews, D; Fischer, L; Schnautz, N; Walsh, W; Pontius, AA; Zedar, M; Kaats, G; Comings, DE

    Full Name of Authors: Blum, K; Braverman, ER; Wu, S; Cull, JG; Chen, TJH; Gill, J; Wood, R; Eisenberg, A; Sherman, M; Davis, KR; Matthews, D; Fischer, L; Schnautz, N; Walsh, W; Pontius, AA; Zedar, M; Kaats, G; Comings, DE

    Keywords by Author: schizoid/avoidant behavior; polymorphisms; dopamine D-2 receptor gene (DRD2); dopamine transporter gene (DAT(1))

    Keywords Plus: PROLONGED P300 LATENCY; PERSONALITY-DISORDERS; BETA-HYDROXYLASE; D2 RECEPTOR; ALLELIC ASSOCIATION; SUBSTANCE-ABUSE; ALCOHOLISM; LINKAGE; LOCUS; VULNERABILITY

    Abstract: The dopaminergic system, and in particular the dopamine D-2 receptor, has been implicated in reward mechanisms in the brain. Dysfunction of the D-2 dopamine receptors leads to aberrant substance-seeking behaviors (ethanol, drugs, tobacco, and food) and other related behaviors (pathological gambling, Tourette's disorder, attention-deficit/hyperactivity disorder). This is the first study supporting a strong association between the dopamine D-2 receptor Tag A(1) allele with schizoid/avoidant behavior (SAB). Additionally, an albeit weaker association between the 480-bp VNTR 10/10 allele of the dopamine transporter (DAT(1)) gene with SAB was similarly found.

    Cate of OECD: Biological sciences

    Year of Publication: 1997

    Business Area: gamble

    Detail Business: gamble

    Country: England

    Study Area: culture, tour, personal, dopamine, drug

    Name of Journal: MOLECULAR PSYCHIATRY

    Language: English

    Country of Authors: NYU,SCH MED,DEPT PSYCHIAT,NEW YORK,NY 10010; CITY HOPE NATL MED CTR,DEPT MED GENET,DUARTE,CA 91010; KANTROLL INC,SAN ANTONIO,TX 78209; CHANG JUNG UNIV,TAINAN,TAIWAN; UTHSC,DEPT COMP RESOURCES,SAN ANTONIO,TX; UNIV N TEXAS,CTR HLTH SCI,DEPT PATHOL,DNA IDENT LAB,FT WORTH,TX 76107; COMPREHENS NEUROBEHAV SYST,AUSTIN,TX 78246; SAN MARCOS TREATMENT CTR,SAN MARCOS,TX 78667; HLTH RES INST,PFEIFFER TREATMENT CTR,NAPERVILLE,IL 60563; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT PSYCHIAT,BOSTON,MA 02114; HLTH & MED RES FDN,SAN ANTONIO,TX 78209

    Press Adress: Blum, K (reprint author), UNIV TEXAS,HLTH SCI CTR,SCH PUBL HLTH HOUSTON,DEPT BEHAV SCI,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284, USA.

    Email Address:

    Citaion:

    Funding:

    Lists of Citation: AMADEO S, 1993, J PSYCHIAT RES, V27, P173, DOI 10.1016/0022-3956(93)90005-M; ARINAMI T, 1993, BIOL PSYCHIAT, V33, P108, DOI 10.1016/0006-3223(93)90309-2; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; BLUM K, 1996, J ROYAL SOC MED, V87, P396; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; BLUM K, 1994, PHARMACOGENETICS, V4, P313, DOI 10.1097/00008571-199412000-00004; Blum K, 1996, AM SCI, V84, P132; BLUM K, 1995, PHARMACOGENETICS, V5, P121, DOI 10.1097/00008571-199506000-00001; BLUM K, 1996, PHARMACOGENETICS, V34, P297; BOELLER DM, 1991, P NATL ACAD SCI USA, V88, P7778; BOLOS AM, 1990, JAMA-J AM MED ASSOC, V264, P3156; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975; CLONINGER CR, 1991, JAMA-J AM MED ASSOC, V266, P1833; CLONINGER CR, 1994, CLIN GENET, V46, P124; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; Comings DE, 1996, PHARMACOGENETICS, V6, P223, DOI 10.1097/00008571-199606000-00004; Comings DE, 1996, BIOL PSYCHIAT, V40, P368, DOI 10.1016/0006-3223(95)00519-6; Comings DE, 1996, MOL PSYCHIATR, V1, P325; COMINGS DE, 1996, DISCOVERY TOURETTE S; COMINGS DE, 1994, DRUG ALCOHOL DEPEN, V34, P175, DOI 10.1016/0376-8716(94)90154-6; Comings DE, 1996, AM J MED GENET, V67, P264, DOI 10.1002/(SICI)1096-8628(19960531)67:3<264::AID-AJMG4>3.0.CO;2-N; Compton PA, 1996, BIOL PSYCHIAT, V39, P302, DOI 10.1016/0006-3223(95)00476-9; CONNEALLY PM, 1991, ARCH GEN PSYCHIAT, V48, P757; COOK BL, 1992, ALCOHOL CLIN EXP RES, V4, P89; COOK CCH, 1993, PSYCHIAT GENET, V3, P130; COOK EH, 1995, AM J HUM GENET, V56, P993; CORBISIERO JR, 1991, J CLIN PSYCHOL, V47, P291, DOI 10.1002/1097-4679(199103)47:2<291::AID-JCLP2270470217>3.0.CO;2-S; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; DAHL AA, 1994, CLIN GENET, V46, P138; DAMATO T, 1989, NUCLEIC ACIDS RES, V17, P5871; DEVOR EJ, 1992, JAMA-J AM MED ASSOC, V267, P651; DUNN OJ, 1995, APPLIED STATISTICS A; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Fahlen T, 1995, J CLIN PSYCHIAT, V56, P569; FALSSTEWART W, 1992, J PERS ASSESS, V59, P515, DOI 10.1207/s15327752jpa5903_7; FLANAGAN SD, 1992, ANN M AM PSYCH M NEW; GELERNTER J, 1991, JAMA-J AM MED ASSOC, V47, P1073; GEORGE SR, 1993, BIOCHEM BIOPH RES CO, V196, P107, DOI 10.1006/bbrc.1993.2222; GOLDMAN D, 1992, ACTA PSYCHIAT SCAND, V86, P351, DOI 10.1111/j.1600-0447.1992.tb03279.x; GOLDMAN D, 1993, ALCOHOL CLIN EXP RES, V17, P199, DOI 10.1111/j.1530-0277.1993.tb00749.x; HINSHAW SP, 1992, J CONSULT CLIN PSYCH, V60, P274, DOI 10.1037/0022-006X.60.2.274; Johnson JG, 1995, J PERS DISORD, V9, P318; KRANZLER HR, 1994, COMPR PSYCHIAT, V35, P335, DOI 10.1016/0010-440X(94)90272-0; LAMOUROUX A, 1993, J NEUROCHEM, V60, P364, DOI 10.1111/j.1471-4159.1993.tb05861.x; LAMOUROUX A, 1987, EMBO J, V6, P3931; MALISON RT, 1995, AM J PSYCHIAT, V152, P1359; MATANO RA, 1994, J PERS ASSESS, V63, P250, DOI 10.1207/s15327752jpa6302_5; MURAMATSU T, 1995, BIOCHEM BIOPH RES CO, V211, P28, DOI 10.1006/bbrc.1995.1773; NEISWANGER K, 1993, PSYCHIATRIC GENETICS, V3, P130; NEISWANGER K, 1995, AM J MED GENET, V60, P272, DOI 10.1002/ajmg.1320600403; NOBLE EP, 1994, MED HYPOTHESES, V42, P257, DOI 10.1016/0306-9877(94)90127-9; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; NOBLE EP, 1994, INT J EAT DISORDER, V15, P205, DOI 10.1002/1098-108X(199404)15:3<205::AID-EAT2260150303>3.0.CO;2-P; NOBLE EP, 1994, AM J HUM GENET, V54, P658; NOBLE EP, 1993, BEHAV GENET, V23, P117; OBOYLE M, 1993, J PERSONALITY DISORD, V7, P32; OHANNESSIAN CM, 1995, J STUD ALCOHOL, V56, P318; OHARA BF, 1993, HUM HERED, V43, P209, DOI 10.1159/000154133; PARSIAN A, 1991, ARCH GEN PSYCHIAT, V48, P655; PATO CN, 1993, AM J MED GENET, V48, P78, DOI 10.1002/ajmg.1320480204; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; PONTIUS AA, 1996, B AM ACAD PSYCHAIT L, V24, P1; Sandbrink R, 1996, MOL PSYCHIATR, V1, P27; SCHULER CE, 1994, J CLIN PSYCHOL, V50, P220, DOI 10.1002/1097-4679(199403)50:2<220::AID-JCLP2270500211>3.0.CO;2-J; SMITH SS, 1992, ARCH GEN PSYCHIAT, V49, P723; SMITH SS, 1991, JAMA-J AM MED ASSOC, V256, P2667; SUAREZ BK, 1994, GENOMICS, V19, P12, DOI 10.1006/geno.1994.1005; TIIHONEN J, 1995, NAT MED, V1, P654, DOI 10.1038/nm0795-654; TURNER E, 1992, BIOL PSYCHIAT, V31, P285, DOI 10.1016/0006-3223(92)90052-2; UHL G, 1993, TRENDS NEUROSCI, V16, P83, DOI 10.1016/0166-2236(93)90128-9; UHL GR, 1994, IN PRESS NIDA MONOGR; UMBERKOMANWIITA B, 1981, RES COMMUN PSYCH PSY, V6, P303; VANDENBERGH DJ, 1992, GENOMICS, V14, P1866; VANYUKOV MM, 1995, AM J MED GENET, V60, P122, DOI 10.1002/ajmg.1320600207; YANOVSKI SZ, 1993, AM J PSYCHIAT, V150, P1472; ZIMMERMAN M, 1994, ARCH GEN PSYCHIAT, V51, P225

    Number of Citaion: 79

    Publication: STOCKTON PRESS

    City of Publication: BASINGSTOKE

    Address of Publication: HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS

    ISSN: 1359-4184

    29-Character Source Abbreviation: MOL PSYCHIATR

    ISO Source Abbreviation: Mol. Psychiatr.

    Volume: 2

    Version: 3

    Start of File: 239

    End of File: 246

    DOI: 10.1038/sj.mp.4000261

    Number of Pages: 8

    Web of Science Category: Biochemistry & Molecular Biology; Neurosciences; Psychiatry

    Subject Category: Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry

    Document Delivery Number: WY048

    Unique Article Identifier: WOS:A1997WY04800013

    [ÀÌ °Ô½Ã¹°Àº HyeJung Mo¡¦´Ô¿¡ ÀÇÇØ 2015-05-20 21:15:05 GAMBLING¿¡¼­ À̵¿ µÊ]
    reply : 0
  • list
  • prev
  • next